Shandong Xinhua Pharmaceutical Company Limited (HKG:0719)

HKG:0719 Ratios and Metrics

Market cap in millions HKD. Fiscal year is January - December.

Fiscal Year	Current	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Apr 9, 2025	Dec 31, 2024	Dec 31, 2023	Jan 1, 2023	Dec 31, 2021	Dec 31, 2020
Market Capitalization	8,205	9,282	11,897	17,740	6,846	5,447
Market Cap Growth	-21.98%	-21.98%	-32.94%	159.15%	25.67%	25.64%
Enterprise Value	8,894	10,083	12,706	17,708	8,175	6,459
Last Close Price	5.35	5.81	5.46	7.41	4.12	3.01
PE Ratio	7.39	18.56	21.75	38.17	16.00	14.12
PS Ratio	0.40	1.03	1.33	2.09	0.85	0.76
PB Ratio	0.67	1.67	2.26	3.61	1.53	1.35
P/TBV Ratio	1.74	1.97	2.66	4.30	1.86	1.65
P/FCF Ratio	22.35	56.20	-	30.56	563.90	32.76
P/OCF Ratio	23.73	23.73	40.71	20.70	21.52	10.92
EV/Sales Ratio	0.99	1.12	1.42	2.09	1.01	0.91
EV/EBITDA Ratio	7.28	8.35	11.27	16.45	7.93	6.45
EV/EBIT Ratio	14.02	15.89	22.52	33.62	16.50	11.86
EV/FCF Ratio	53.86	61.05	-	30.51	673.39	38.85
Debt / Equity Ratio	0.32	0.32	0.28	0.32	0.45	0.49
Debt / EBITDA Ratio	1.45	1.45	1.32	1.45	1.95	1.95
Debt / FCF Ratio	10.74	10.74	-	2.70	166.46	11.75
Asset Turnover	0.98	0.98	0.98	0.96	0.91	0.89
Inventory Turnover	4.97	4.97	4.58	4.93	4.48	3.77
Quick Ratio	0.85	0.85	0.76	0.68	0.65	0.59
Current Ratio	1.33	1.33	1.33	1.09	1.10	1.13
Return on Equity (ROE)	9.74%	9.74%	11.09%	10.65%	10.28%	10.68%
Return on Assets (ROA)	4.31%	4.31%	3.87%	3.73%	3.50%	4.24%
Return on Capital (ROIC)	5.73%	5.73%	5.39%	5.28%	4.88%	5.93%
Return on Capital Employed (ROCE)	9.60%	9.60%	8.80%	9.10%	8.40%	9.70%
Earnings Yield	6.10%	5.39%	4.60%	2.62%	6.25%	7.08%
FCF Yield	2.01%	1.78%	-0.55%	3.27%	0.18%	3.05%
Dividend Yield	5.46%	-	5.05%	3.05%	4.46%	5.92%
Payout Ratio	48.05%	48.05%	35.43%	39.66%	42.59%	39.05%
Buyback Yield / Dilution	-0.23%	0.11%	-3.20%	-6.93%	0.02%	-0.86%
Total Shareholder Return	5.23%	0.11%	1.85%	-3.87%	4.48%	5.06%

Updated Oct 29, 2024. Source: S&P Global Market Intelligence. Standard template. Financial Sources.